Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Benjamin T Dake. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Benjamin T Dake har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:AVTE / Aerovate Therapeutics, Inc. SEE REMARKS 14.252
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Benjamin T Dake. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Benjamin T Dake som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-08-02 2024-08-01 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise 1.507 14.252 11,82 1,74 2.622 24.798
2024-08-02 2024-07-31 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise 11.454 12.745 887,22 1,74 19.930 22.176
2024-04-19 2024-04-17 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -68 1.291 -5,00 23,97 -1.630 30.945
2024-04-19 2024-04-17 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -338 1.359 -19,92 23,17 -7.831 31.488
2024-04-19 2024-04-17 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -6.447 1.697 -79,16 22,32 -143.865 37.869
2024-04-19 2024-04-17 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 6.853 8.144 530,83 2,14 14.665 17.428
2024-04-03 2024-04-01 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3.325 1.291 -72,03 31,97 -106.317 41.280
2024-04-03 2024-04-01 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 3.325 4.616 257,55 10,61 35.278 48.976
2024-03-28 2024-03-27 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -11.068 1.291 -89,55 27,97 -309.519 36.103
2024-03-28 2024-03-27 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 11.068 12.359 857,32 10,61 117.431 131.129
2024-03-27 2024-03-25 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3.432 1.291 -72,67 28,01 -96.119 36.157
2024-03-27 2024-03-25 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 3.432 4.723 265,84 10,61 36.414 50.111
2024-03-20 2024-03-18 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -7.581 1.291 -85,45 26,48 -200.764 34.189
2024-03-20 2024-03-18 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -27.476 8.872 -75,59 25,74 -707.282 228.381
2024-03-20 2024-03-18 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 14.500 36.348 66,37 10,61 153.845 385.652
2024-03-20 2024-03-18 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 20.557 21.848 1.592,33 2,14 43.992 46.755
2023-12-07 2023-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -10.283 1.291 -88,85 16,11 -165.628 20.794
2023-12-07 2023-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7.872 11.574 212,64 2,14 16.846 24.768
2023-12-07 2023-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.411 3.702 186,75 1,74 4.195 6.441
2023-11-29 2023-11-27 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -12.517 1.291 -90,65 16,24 -203.237 20.962
2023-11-29 2023-11-27 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 10.104 13.808 272,79 2,14 21.623 29.549
2023-11-29 2023-11-27 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.413 3.704 186,91 1,74 4.199 6.445
2023-11-27 2023-11-24 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -70 1.291 -5,14 16,07 -1.125 20.741
2023-11-27 2023-11-24 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -4.920 1.361 -78,33 15,74 -77.423 21.417
2023-11-27 2023-11-24 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 4.990 6.281 386,52 2,14 10.679 13.441
2023-11-27 2023-11-22 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -9.382 1.291 -87,90 15,17 -142.359 19.589
2023-11-27 2023-11-22 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 6.970 10.673 188,23 2,14 14.916 22.840
2023-11-27 2023-11-22 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.412 3.703 186,83 1,74 4.197 6.443
2023-09-08 2023-09-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -30 1.291 -2,27 15,01 -450 19.378
2023-09-08 2023-09-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 30 1.321 2,32 2,14 64 2.827
2023-09-08 2023-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3.931 1.291 -75,28 15,06 -59.187 19.438
2023-09-08 2023-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 1.518 5.222 40,98 2,14 3.249 11.175
2023-09-08 2023-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.413 3.704 186,91 1,74 4.199 6.445
2023-08-09 2023-08-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -541 1.291 -29,53 16,25 -8.789 20.972
2023-08-09 2023-08-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -9.742 1.832 -84,17 15,48 -150.792 28.357
2023-08-09 2023-08-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7.871 11.574 212,56 2,14 16.844 24.768
2023-08-09 2023-08-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.412 3.703 186,83 1,74 4.197 6.443
2023-07-07 2023-07-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -10.283 1.291 -88,85 16,66 -171.284 21.504
2023-07-07 2023-07-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7.871 11.574 212,56 2,14 16.844 24.768
2023-07-07 2023-07-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.412 3.703 186,83 1,74 4.197 6.443
2023-06-08 2023-06-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -15 1.291 -1,15 16,98 -255 21.915
2023-06-08 2023-06-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -10.268 1.306 -88,72 16,28 -167.161 21.261
2023-06-08 2023-06-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7.871 11.574 212,56 2,14 16.844 24.768
2023-06-08 2023-06-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.412 3.703 186,83 1,74 4.197 6.443
2023-05-09 2023-05-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1.599 1.291 -55,33 22,74 -36.355 29.352
2023-05-09 2023-05-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -8.685 2.890 -75,03 21,62 -187.805 62.494
2023-05-09 2023-05-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7.871 11.575 212,50 2,14 16.844 24.770
2023-05-09 2023-05-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.413 3.704 186,91 1,74 4.199 6.445
2023-04-07 2023-04-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -10.283 0 -100,00 18,17 -186.829
2023-04-07 2023-04-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7.871 10.283 326,33 2,14 16.844 22.006
2023-04-07 2023-04-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.412 2.412 1,74 4.197 4.197
2023-03-08 2023-03-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -215 0 -100,00 24,50 -5.267
2023-03-08 2023-03-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -10.067 215 -97,91 23,71 -238.687 5.098
2023-03-08 2023-03-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7.870 10.282 326,29 2,14 16.842 22.003
2023-03-08 2023-03-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.412 2.412 1,74 4.197 4.197
2023-02-08 2023-02-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1.426 0 -100,00 25,02 -35.679
2023-02-08 2023-02-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -8.858 1.426 -86,13 24,52 -217.203 34.966
2023-02-08 2023-02-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7.872 10.284 326,37 2,14 16.846 22.008
2023-02-08 2023-02-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.412 2.412 1,74 4.197 4.197
2023-01-09 2023-01-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -2.792 0 -100,00 26,95 -75.254
2023-01-09 2023-01-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -7.492 2.792 -72,85 25,62 -191.949 71.532
2023-01-09 2023-01-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7.871 10.284 326,19 2,14 16.844 22.008
2023-01-09 2023-01-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.413 2.413 1,74 4.199 4.199
2022-12-14 2022-12-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -907 0 -100,00 30,26 -27.443
2022-12-14 2022-12-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1.132 907 -55,52 28,83 -32.632 26.146
2022-12-14 2022-12-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -20 2.039 -0,97 25,82 -516 52.647
2022-12-14 2022-12-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.059 2.059 2,14 4.406 4.406
2022-12-12 2022-12-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -394 0 -100,00 25,03 -9.861
2022-12-12 2022-12-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 394 394 2,14 843 843
2022-12-12 2022-12-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3.178 0 -100,00 24,08 -76.533
2022-12-12 2022-12-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3.199 3.178 -50,16 22,56 -72.178 71.705
2022-12-12 2022-12-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -2.695 6.377 -29,71 21,63 -58.302 137.957
2022-12-12 2022-12-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -928 9.072 -9,28 20,94 -19.435 189.996
2022-12-12 2022-12-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 10.000 10.000 2,14 21.400 21.400
2022-12-08 2022-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -615 0 -100,00 18,29 -11.250
2022-12-08 2022-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -36.115 615 -98,33 17,80 -642.861 10.947
2022-12-08 2022-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1.259 36.730 -3,31 16,90 -21.275 620.678
2022-12-08 2022-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -2.011 37.989 -5,03 15,61 -31.386 592.906
2022-12-08 2022-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 37.588 40.000 1.558,37 2,14 80.438 85.600
2022-12-08 2022-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.412 2.412 1,74 4.197 4.197
2022-11-14 2022-11-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -121 0 -100,00 22,20 -2.686
2022-11-14 2022-11-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1.625 121 -93,07 21,41 -34.796 2.591
2022-11-14 2022-11-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -4.452 1.746 -71,83 20,39 -90.754 35.592
2022-11-14 2022-11-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 6.198 6.198 2,14 13.264 13.264
2022-11-14 2022-11-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1.800 0 -100,00 20,10 -36.172
2022-11-14 2022-11-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 1.800 1.800 2,14 3.852 3.852
2022-11-14 2022-11-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -14.000 0 -100,00 17,91 -250.677
2022-11-14 2022-11-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 14.000 14.000 2,14 29.960 29.960
2022-11-09 2022-11-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -8.373 0 -100,00 18,09 -151.458
2022-11-09 2022-11-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 8.373 8.373 2,14 17.918 17.918
2022-11-09 2022-11-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1.660 0 -100,00 20,24 -33.594
2022-11-09 2022-11-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1.486 1.660 -47,23 19,57 -29.081 32.486
2022-11-09 2022-11-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3.359 3.146 -51,64 18,58 -62.399 58.443
2022-11-09 2022-11-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -11.122 6.505 -63,10 17,79 -197.819 115.700
2022-11-09 2022-11-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 15.214 17.627 630,50 2,14 32.558 37.722
2022-11-09 2022-11-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.413 2.413 1,74 4.199 4.199
2022-10-20 2022-10-18 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -5.705 0 -100,00 21,08 -120.287
2022-10-20 2022-10-18 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 5.705 5.705 2,14 12.209 12.209
2022-10-18 2022-10-17 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -4.185 0 -100,00 20,16 -84.380
2022-10-18 2022-10-17 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 4.185 4.185 2,14 8.956 8.956
2022-10-18 2022-10-14 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -110 0 -100,00 20,05 -2.206
2022-10-18 2022-10-14 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 110 110 2,14 235 235
2022-10-12 2022-10-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1.430 0 -100,00 17,26 -24.689
2022-10-12 2022-10-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3.524 1.430 -71,13 16,74 -58.992 23.938
2022-10-12 2022-10-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 4.954 4.954 2,14 10.602 10.602
2022-10-11 2022-10-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1.757 0 -100,00 16,41 -28.828
2022-10-11 2022-10-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -8.763 1.757 -83,30 15,93 -139.631 27.996
2022-10-11 2022-10-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 10.520 10.520 2,14 22.513 22.513
2022-10-11 2022-10-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -948 0 -100,00 17,31 -16.411
2022-10-11 2022-10-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -882 948 -48,20 16,54 -14.589 15.680
2022-10-11 2022-10-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -11.210 1.830 -85,97 15,64 -175.345 28.624
2022-10-11 2022-10-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 10.629 13.040 440,85 2,14 22.746 27.906
2022-10-11 2022-10-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2.411 2.411 1,74 4.195 4.195
2022-09-14 2022-09-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -272 0 -100,00 18,77 -5.105
2022-09-14 2022-09-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1.976 272 -87,90 18,26 -36.087 4.967
2022-09-14 2022-09-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -5.272 2.248 -70,11 16,90 -89.115 37.999
2022-09-14 2022-09-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7.520 7.520 2,14 16.093 16.093
2022-09-12 2022-09-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -176 0 -100,00 18,54 -3.262
2022-09-12 2022-09-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -4.544 176 -96,27 17,50 -79.540 3.081
2022-09-12 2022-09-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 4.462 4.720 1.729,46 2,14 9.549 10.101
2022-09-12 2022-09-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 258 258 1,74 449 449
2022-09-12 2022-09-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -629 0 -100,00 18,42 -11.588
2022-09-12 2022-09-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -2.491 629 -79,84 18,14 -45.193 11.412
2022-09-12 2022-09-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 3.120 3.120 1,74 5.429 5.429
2022-09-08 2022-09-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3.658 0 -100,00 18,42 -67.386
2022-09-08 2022-09-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -5 3.658 -0,12 18,12 -83 66.270
2022-09-08 2022-09-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 8.220 8.220 1,74 14.303 14.303
2022-09-08 2022-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -606 0 -100,00 19,78 -11.984
2022-09-08 2022-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -4.138 606 -87,23 18,98 -78.546 11.503
2022-09-08 2022-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -4.422 4.744 -48,24 17,94 -79.345 85.123
2022-09-08 2022-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 9.166 9.166 1,74 15.949 15.949
2022-08-18 2022-08-16 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3.451 0 -100,00 24,10 -83.174
2022-08-18 2022-08-16 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -7.074 3.451 -67,21 23,29 -164.724 80.360
2022-08-18 2022-08-16 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -10.475 10.525 -49,88 22,44 -235.034 236.156
2022-08-18 2022-08-16 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 21.000 21.000 1,74 36.540 36.540
2022-08-12 2022-08-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -79 0 -100,00 24,55 -1.939
2022-08-12 2022-08-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1.268 79 -94,14 23,89 -30.292 1.887
2022-08-12 2022-08-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 1.347 1.347 1,74 2.344 2.344
2022-08-12 2022-08-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -780 0 -100,00 24,48 -19.096
2022-08-12 2022-08-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -11.940 780 -93,87 24,06 -287.270 18.766
2022-08-12 2022-08-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 12.720 12.720 1,74 22.133 22.133
2022-08-10 2022-08-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -2.791 0 -100,00 24,52 -68.436
2022-08-10 2022-08-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -5.909 2.791 -67,92 23,84 -140.889 66.546
2022-08-10 2022-08-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 8.700 8.700 1,74 15.138 15.138
2022-08-10 2022-08-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -2.954 0 -100,00 24,94 -73.678
2022-08-10 2022-08-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3.989 2.954 -57,45 24,39 -97.283 72.042
2022-08-10 2022-08-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 6.943 6.943 1,74 12.081 12.081
2021-12-16 2021-12-14 4 AVTE Aerovate Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 58.000 58.000
2021-07-01 2021-06-29 4 AVTE Aerovate Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 180.800 180.800
2021-07-01 2021-04-02 4 AVTE Aerovate Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 328.921 328.921
2021-07-01 2021-04-02 4 AVTE Aerovate Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 48.882 48.882
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)